Weed stocks over sold from tax loss harvesting?Ive traded gtbif green thumb successful before and think this might be the time to trade again. Gtbif is one of the biggest holdings inside this Msos etf.
I like the etf MSOS, the shares of GTBIF, and any of the other profitable Cannabis stocks.
Looking for mean reversion, even 2x upside potentially.
Long 3 strike calls on MSOS.
if trade in options works, I may roll back into the etf and keep for free from gains.
Weedstocks
Planet 13 Holdings | PLNH | Long at $0.39The marijuana sector has taken a beating over the last few years, yet certain companies may provide value and dominate the space in the future. Enter Planet 13 Holdings $OTC:PLNH. This OTC play warrants extreme caution, though. It's either going to zero or could produce massive returns. My personal logic is not to bet the farm with any OTC play, but maybe an old goat ... and potentially buy the farm in the future.
From a technical analysis perspective, my selected historical simple moving average (SMA) line is approaching the current price of $0.39. Frequently, as this SMA line and price get closer to each other, there is a pop in the price.
Fundamentally, financial growth is anticipated. Financial highlights from the Q3 2024 report state that the company's revenue was $32.2 million as compared to $24.8 million, an increase of 29.7%. The increase in sales was driven by the addition of Florida as well as strong sales in Illinois. Gross profit was $16.7 million or 51.9% as compared to $11.1 million or 44.7%. Free cash flow: $108,807 million. Operationally, OTC:PLNH looks pretty good on paper.
Marijuana legalization in the US is only going to expand. It's inevitable given the changing sentiment around the topic. If OTC:PLNH can do well in this space and is able to continue to grow, this ticker could get very interest. Thus, at $0.39, OTC:PLNH is in a personal buy zone.
Target #1: $0.55
Target #2: $0.75
Target #3: $1.00
Target #4: $5.75 (very long-term outlook if legalization spreads...)
GrowGeneration | GRWG | Long at $1.90GrowGeneration NASDAQ:GRWG is approaching one of my favorite technical analysis setups as it gets closer to my selected historical simple moving average (SMA: the white and teal lines). Often, but not always (i.e. public offering news...), the price will jump to the selected historical SMA after a long period of consolidation - which has been occurring for some time. Additionally, the President, CEO, and Director of NASDAQ:GRWG have been buying shares recently near $2 which is a bullish indicator. There are currently only 54.8 million floating shares and an 8%+ short interest, so this could get interesting if the election cycle whips up new interest/chatter about national decriminalization of marijuana. As a result, GrowGeneration is in a personal buy zone at $1.90.
Target #1 = $2.20
Target #2 = $2.50
Target #3 = $3.00
Target #4 = $3.50
WM Technology | MAPS | Long at $1.00WM Technology NASDAQ:MAPS provides ecommerce and compliance software solutions to retailers and brands in cannabis market in the United States and internationally. After it's de-SPAC in 2020, it soared to $29.50 and now can be found for around $1.00. It's been consolidating at these lows for almost two years, and it may be gaining algorithmic traction for a move soon based on my selected simple moving average (SMA). Often (but not always), when this SMA gets close to the price, there is a pop to the historical SMA. Currently, it is in a personal buy zone at $1.00.
Target #1 = $1.50
Target #2 = $2.00
Tilray - Its timeTilray has completed a type 2 bullish shark and caught followthrough price action on Friday.
Long to the three targets. If you are seeing this late then I'd wait on a down day to enter, if it never comes then you've missed the entry and another opportunity will arise.
We are also long on SNDL with a similar but weaker setup
send $acb back to $1002024 has been very busy for NASDAQ:ACB
- Aurora Introduces Medical Cannabis Pastilles for Patient Relief in Australia
- Aurora Completes Final Repayment of Convertible Senior Notes Representing ~$465 Million in Total Repayments Since 2021; Cannabis Operations Are Now Debt Free
- Aurora Partners with Script Assist to Provide Better Access to UK Medical Cannabis
- Aurora Cannabis Announces CFO Transition and Completion of Previously Announced Share Consolidation
when looking at the chart we can see obvious price discovery to the downside, and the last year of lows have come with heavy market selling. however on the plus side the buy pressure has been positive in the background suggesting someone is happy to scoop up the stock down here.
its only a matter of time before NASDAQ:ACB picks up again given the company are now debt free :-)
"Canopy Growth Corporation Faces Critical Support Test"Canopy Growth Corporation: Navigating Market Challenges and Strategic Goals
Canopy Growth Corporation, a prominent player in the cannabis industry, has been a focal point for investors seeking exposure to the rapidly expanding market for legal marijuana products. As one of the largest cannabis producers globally, Canopy Growth has garnered attention for its ambitious goals and strategic initiatives aimed at capitalizing on the burgeoning demand for cannabis-related products.
Founded in 2013, Canopy Growth has quickly risen to prominence, establishing itself as a leader in the cannabis industry through a combination of strategic acquisitions, innovative product development, and global expansion efforts. The company's primary focus is on cultivating, producing, and distributing a diverse range of cannabis products, including dried flower, oils, edibles, and beverages.
In recent years, Canopy Growth has achieved several notable milestones, reflecting its commitment to growth and innovation. These achievements include expanding its production capacity, securing distribution agreements with leading retailers, and launching new product lines to meet evolving consumer preferences.
However, despite its successes, Canopy Growth has faced challenges in navigating the volatile cannabis market, particularly in the wake of a prolonged distribution bear market that has persisted for the past five years. The company's stock price has experienced significant fluctuations, reflecting the uncertainty surrounding regulatory environments, shifting consumer trends, and competitive pressures within the industry.
Recently, Canopy Growth's stock price experienced a sharp retracement, testing critical support levels around $18 per share. With the stock now poised to retest its previous lows at $4 per share, investors are closely monitoring the situation for signs of a potential breakout or breakdown.
The recent spike in volume accompanying the bounce from support suggests heightened volatility and the potential for significant price movements in the near term. Bears may attempt to crack support levels, with the possibility of a further downward spiral if volume flows through aggressively enough. In such a scenario, the stock could potentially retest long-term downward support levels around $2 per share.
On the other hand, if Canopy Growth manages to break out of its current pennant pattern, investors may view this as an opportunity to enter a position targeting the top of long-term resistance levels. A successful breakout could pave the way for renewed upward momentum, offering potential upside for savvy traders.
In conclusion, Canopy Growth Corporation continues to navigate challenges in the cannabis market while pursuing strategic goals aimed at driving long-term growth and profitability. As the company grapples with support levels and potential breakout opportunities, investors should remain vigilant and adaptable, prepared to capitalize on emerging trends and developments in this dynamic industry.
TLRY's Green Revolution Cannabis Stocks on the NYSEAs of the most recent data, the S&P 500, which represents the performance of 500 of the largest companies listed on stock exchanges in the United States, is trading at an impressive level. The index has been on a bullish trend, consistently reaching new all-time highs in recent months. This upward trajectory can be attributed to a combination of factors, including strong corporate earnings, optimism surrounding economic recovery, and accommodative monetary policies from central banks. Investors' appetite for risk remains robust, and as long as these favorable conditions persist, the S&P 500's bullish trend is likely to continue, attracting both institutional and retail investors.
MSOS wanna get HIGH?erf you find this information inspiring/helpful, please consider a boost and follow! Any questions or comments, please leave a comment! Also, check out the links in my signature to get to know me better!
MSOS News pump, so a short based off of past trends could be warrented, but watching for a nice correction and some reactions off of these levels starting at 6.44 and 5.56.
SHORT Leafly - lost over 99% since the IPO.Since the IPO, Leafly has lost over 99% of its value.
Leafly's management team throws shares at retail investors on a monthly basis and feeds the short positions of hedge funds.
As long as Leafly continues to get beat up by hedge funds, prices will continue to fall.
There is steadily more selling than buying. The demand is very low.
In the long term, the stock could be interesting.
GRWG buy the dip!First off for summary:
Grow Generation is a leading retailer of hydroponic and organic gardening products in the United States. The company was founded in 2014 and is headquartered in Denver, Colorado. Grow Generation provides a wide range of products and services for indoor and outdoor gardening, including hydroponic and organic growing equipment, nutrients, and supplies. The company operates more than 30 retail locations in 13 states and is committed to providing high-quality products, expert advice, and excellent customer service to its customers. With a growing customer base of professional cultivators and home gardeners, Grow Generation is well positioned for continued growth in the hydroponic and organic gardening industries.
TA: It is very clear we are under the 5year trend line.
In 2018/2019 when GRWG was at these prices the revenue was a 4th of what it is now so even with the marco economic outlook uncertain, I think this is a great buying opportunity.
These guys are growing at a healthy rate and there is still a large untapped market in the midwest that they are positioned well to capture. I've been watching more and more folks convert from alcohol to delta 8 products and it's only a matter of time before the feds decriminalize delta 9 sales.
I think we will break above $10 by summer.
If we test new lows I'd reconsider.
Aurora: Sleeping Beauty 👸It's time to activate our wake-up call to get Aurora back into motion, since we expect the course to rise up North, even though it is still creeping sideways momentarily. In our alternative scenario, there is a slight probability of 33% that the course could drop below the $1.14 support line instead. In this case, it would continue to move South until it reaches the low of the grey wave alt. II. Primarily, the stock should make the climb and fulfill the blue wave (iii) before dropping into a correction of the blue wave (iv). Once completed, the course should have gained momentum to be able to exceed the resistance line at $2.49 and wander further North in order to complete the pink wave .
Jazz Pharmaceuticals: High Life 🍁It must be 420 somewhere, since the Jazz Pharmaceuticals stock is paving its way higher and higher to ultimately reach the orange target zone. Once the blue wave (b) is completed, the stock should drop all the way below the $125.36 support line and continue the correction until the end of the green wave within the yellow trading area. Once the course has hit the corrective low, it can turn back up and start a sturdy upwards trend.
Canopy Growth: Ball Drop 🪩Just like the Ball in Times Square every New Year's Eve, the Canopy Growth stock is currently dropping it low. We expect the course to dig deeper into the blue trading area between C$3.49 and C$0.70 until it finishes the grey wave II. After completion, we're expecting the course to rise further North in the longterm. In our alternative scenario, the Canopy Growth stock course might exceed the C$5.55-mark already now, without pushing for further lows below the support line.
$PSIL Bombed out #Weed #ETF $MSOS attacking resistance lines...Will it pull up the
AdvisorShares Psychedelics ETF?
Strength in the #Biotech sector would also be a friendly situation.
here are the top holdings:
CMPS COMPASS PATHWAYS PLC 13.12%
ATAI ATAI LIFE SCIENCES NV 9.73%
CYBN CYBIN INC 7.97%
SEEL SEELOS THERAPEUTICS INC 6.90%
ITCI INTRA-CELLULAR THERAPIES INC 6.44%
HUGE FSD PHARMA INC-CLASS B 5.82%
SAGE SAGE THERAPEUTICS INC 5.23%
ALKS ALKERMES PLC 4.84%
DRUG BRIGHT MINDS BIOSCIENCES INC 4.70%
I can see this ETF targeting $3.2 as its first port of call.
Bargain Hunting - OBV Divergence?This is just a thought here - although this appears to be a never-ending downtrend, I wonder if this on-balance volume divergence signals something. This shows that buyers are willing to step in here a bit more aggressively than the previous "bottom," as shown by higher OBV despite lower prices - even though OBV has declined overall since its peak. We're also seeing higher OBV in general since 2021, which could signify aggressive accumulation despite continued decline in value. This sort of behavior can be seen throughout the cannabis industry.
ACB is roughly 98-99% down from its all-time high. Not that it could ever get back up there, but I think at least a return to the $6-7 range is possible over the coming months. However, since the downtrend has technically not ended, there is still significant risk of continuation to the downside. Seems worth a speculative gamble though, as per my last stock analysis and being "strategic."
Overall, I'm only down 12% on stocks since I started investing slowly since last year. Not too bad, considering how far down big tech has tumbled. That's probably because I've stayed away from big tech, and been pretty careful about investing too much in weed stocks, at least until prices started to get obscenely low. I also managed to stabilize my portfolio by investing in Uranium ETF's, which helped a bit.
-Victor Cobra
Bullish Bat On Underlooked Cannabis StockI do believ the Cannabis Sector will see a rally later on in the year and this appears to be a very nice place to take an entry on this particular stock.